Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![doepke_michel Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1350720698591936515.png) Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4855 followers
Created: 2025-07-01 13:22:46 UTC

$PTGX Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity. $NVO $LLY $VKTX


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1940038371616657641/c:line.svg)

**Related Topics**
[$lly](/topic/$lly)
[$ptgx](/topic/$ptgx)
[$nvo](/topic/$nvo)
[stocks healthcare](/topic/stocks-healthcare)
[eli lilly](/topic/eli-lilly)
[$vktx](/topic/$vktx)

[Post Link](https://x.com/doepke_michel/status/1940038371616657641)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

doepke_michel Avatar Michel Doepke @doepke_michel on x 4855 followers Created: 2025-07-01 13:22:46 UTC

$PTGX Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity. $NVO $LLY $VKTX

XXXXX engagements

Engagements Line Chart

Related Topics $lly $ptgx $nvo stocks healthcare eli lilly $vktx

Post Link

post/tweet::1940038371616657641
/post/tweet::1940038371616657641